Heart repair and stem cells

Journal of Physiology

Volumn 577, Issue 2, 2006, Pages 467-478

  van Laake, Linda W ^a   Hassink, Rutger ^a   Doevendans, Pieter A ^a,b   Mummery, Christine ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; BONE MARROW CELL; CELL DIFFERENTIATION; CELL TYPE; CLINICAL TRIAL; EMBRYONIC STEM CELL; FUNCTIONAL ASSESSMENT; GRAFT REJECTION; HEART INFARCTION; HEART MUSCLE CELL; HUMAN; MUSCLE CELL; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; CARDIAC STEM CELL; CARDIOMYOCYTE PROGENITOR CELL; CELL TRANSDIFFERENTIATION; CLINICAL TRIAL (TOPIC); ENDOTHELIAL PRECURSOR CELL; HEART FUNCTION; HEART REPAIR; HEMATOPOIETIC STEM CELL; TISSUE REPAIR;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; CORONARY DISEASE; EMBRYONIC STEM CELLS; ENDOTHELIAL CELLS; GRAFT REJECTION; HUMANS; MODELS, ANIMAL; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; RANDOMIZED CONTROLLED TRIALS; REGENERATIVE MEDICINE; SATELLITE CELLS, SKELETAL MUSCLE; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE ENGINEERING; TREATMENT OUTCOME;

EID: 33751347371     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2006.115816     Document Type: Review

References (100)

1. Allegrucci C & Young LE (2006). Differences between human embryonic stem cell lines. Human Reprod Update (in press).
2. Amado LC, Saliaris AP, Schuleri KH et al. (2005). Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A 102, 11474-11479.
3. Asahara T, Murohara T, Sullivan A et al. (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967.
4. Askari AT, Unzek S, Popovic ZB et al. (2003). Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362, 697-703.
5. Balsam LB, Wagers AJ, Christensen JL et al. (2004). Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428, 668-673.
6. Bartunek J, Dimmeler S, Drexler H et al. (2006). The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart. Eur Heart J 27, 1338-1340.
7. Bartunek J, Vanderheyden M, Vandekerckhove B, Mansour S, De Bruyne B, De Bondt P, Van Haute I, Lootens N, Heyndrickx G & Wijns W (2005). Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: Feasibility and safety. Circulation 112, I178-I183.
8. Behfar A, Zingman LV, Hodgson DM et al. (2002). Stem cell differentiation requires a paracrine pathway in the heart. FASEB J 16, 1558-1566.
9. Beltrami AP, Barlucchi L, Torella D et al. (2003). Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114, 763-776.
10. Beqqali A, Kloots J, Ward-van Oostwaard D et al. (2006). Genome-wide transcriptional profiling of human embryonic stem cells differentiating to cardiomyocytes. Stem Cells 24, 1956-1967.
11. Ceradini DJ, Kulkarni AR, Callaghan MJ et al. (2004). Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10, 858-864.
12. Chuva de Sousa Lopes SM, Hassink RJ, Feijen A et al. (2006). Patterning the heart, a template for human cardiomyocyte development. Dev Dyn 235, 1994-2002.
13. Cleland JG, Freemantle N, Coletta AP et al. (2006). Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE. Eur J Heart Fail 8, 105-110.
14. Crosby JR, Kaminski WE, Schatteman G et al. (2000). Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ Res 87, 728-730.
15. Dai W, Hale SL & Kloner RA (2005). Stem cell transplantation for the treatment of myocardial infarction. Transpl Immunol 15, 91-97.
16. Dang SM & Zandstra PW (2005). Scalable production of embryonic stem cell-derived cells. Meth Mol Biol 290, 353-364.
17. Davani S, Deschaseaux F, Chalmers D et al. (2005). Can stem cells mend a broken heart?Cardiovasc Res 65, 305-316.
18. Devlin AM, Moore NR & Ostman-Smith I (1999). A comparison of MRI and echocardiography in hypertrophic cardiomyopathy. Br J Radiol 72, 258-264.
19. Dimarakis I, Habib NA & Gordon MY (2005). Adult bone marrow-derived stem cells and the injured heart: Just the beginning? Eur J Cardiothorac Surg 28, 665-676.
20. Dimmeler S, Zeiher AM & Schneider MD (2005). Unchain my heart: The scientific foundations of cardiac repair. J Clin Invest 115, 572-583.
21. Dobert N, Britten M, Assmus B et al. (2004). Transplantation of progenitor cells after reperfused acute myocardial infacrtion. Evaluation of perfusion and myocardial viability with FDG-PET and thallium SPECT. Eur J Nucl Med Mol Imaging 31, 1146-1151.
22. Dowell JD, Rubart M, Pasumarthi KB et al. (2003). Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc Res 58, 336-350.
23. Drukker M & Benvenisty N (2004). The immunogenicity of human embryonic stem-derived cells. Trends Biotechnol 22, 136-141.
24. Drukker M, Katz G, Urbach A et al. (2002). Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci U S A 99, 9864-9869.
25. Evans MJ & Kaufman MH (1981). Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154-156.
26. Fijnvandraat AC, van Ginneken AC, Schumacher CA et al. (2003). Cardiomyocytes purified from differentiated embryonic stem cells exhibit characteristics of early chamber myocardium. J Mol Cell Cardiol 35, 1461-1472.
27. Gavira JJ, Herreros J, Perez A et al. (2006). Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up. J Thorac Cardiovasc Surg 131, 799-804.
28. Hagege AA, Carrion C, Menasche P et al. (2003). Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 361, 491-492.
29. He JQ, Ma Y, Lee Y et al. (2003). Human embryonic stem cells develop into multiple types of cardiac myocytes: Action potential characterization. Circ Res 93, 32-39.
30. Herreros J, Prosper F, Perez A et al. (2003). Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J 24, 2012-2020.
31. Hierlihy AM, Seale P, Lobe CG et al. (2002). The post-natal heart contains a myocardial stem cell population. FEBS Lett 530, 239-243.
32. Himes N, Min JY, Lee R et al. (2004). In vivo MRI of embryonic stem cells in a mouse model of myocardial infarction. Magn Reson Med 52, 1214-1219.
33. Hodgson DM, Behfar A, Zingman LV et al. (2004). Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol 287, H471-H479.
34. Hool LC (2006). Reactive oxygen species in cardiac signalling: From mitochondria to plasma membrane ion channels. Clin Exp Pharmacol Physiol 33, 146-151.
35. Janssens S, Dubois C, Bogaert J et al. (2006). Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: Double-blind, randomised controlled trial. Lancet 367, 113-121.
36. Kehat I, Kenyagin-Karsenti D, Snir M et al. (2001). Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108, 407-414.
37. Kehat I, Khimovich L, Caspi O et al. (2004). Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 22, 1282-1289.
38. Kinnaird T, Stabile E, Burnett MS et al. (2004). Marrow derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94, 678-685.
39. Kloner RA & Jennings RB (2001). Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: Part 1. Circulation 104, 2981-2989.
40. Klug MG, Soonpaa MH, Koh GY et al. (1996). Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J Clin Invest 98, 216-224.
41. Kocher AA, Schuster MD, Szabolcs MJ et al. (2001). Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7, 430-436.
42. Kofidis T, de Bruin JL, Tanaka M et al. (2005 a). They are not stealthy in the heart: Embryonic stem cells trigger cell infiltration, humoral and T-lymphocyte-based host immune response. Eur J Cardiothorac Surg 28, 461-466.
43. Kofidis T, de Bruin JL, Hoyt G et al. (2004 a). Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle. J Thorac Cardiovasc Surg 128, 571-578.
44. Kofidis T, de Bruin JL, Yamane T et al. (2004 b). Insulin-like growth factor promotes engraftment, differentiation, and functional improvement after transfer of embryonic stem cells for myocardial restoration. Stem Cells 22, 1239-1245.
45. Kofidis T, Lebl DR, Martinez EC et al. (2005 b). Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury. Circulation 112, I173-I177.
46. Kofidis T, Lebl DR, Swijnenburg RJ et al. (2006). Allopurinol/uricase and ibuprofen enhance engraftment of cardiomyocyte-enriched human embryonic stem cells and improve cardiac function following myocardial injury. Eur J Cardiothorac Surg 29, 50-55.
47. van Laake LW, Van Hoof D & Mummery CL (2005). Cardiomyocytes derived from stem cells. Ann Med 37, 499-512.
48. Laflamme MA, Gold J, Xu C et al. (2005). Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol 167, 663-671.
49. Laflamme MA & Murry CE (2005). Regenerating the heart. Nat Biotechnol 23, 845-856.
50. Laugwitz KL, Moretti A, Lam J et al. (2005). Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433, 647-653.
51. Lebrin F, Goumans MJ, Jonker L et al. (2004). Endoglin promotes endothelial cell proliferation and TGF-β/ALK1 signal transduction. EMBO J 23, 4018-4028.
52. Leobon B, Garcin I, Menasche P et al. (2003). Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci U S A 100, 7808-7811.
53. Li TS, Hayashi M, Ito H et al. (2005). Regeneration of infarcted myocardium by intramyocardial implantation of ex vivo transforming growth factor-β-preprogrammed bone marrow stem cells. Circulation 111, 2438-2445.
54. Limbourg FP, Ringes-Lichtenberg S, Schaefer A et al. (2005). Haematopoietic stem cells improve cardiac function after infarction without permanent cardiac engraftment. Eur J Heart Fail 7, 722-729.
55. Lin Q, Schwarz J, Bucana C et al. (1997). Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276, 1404-1407.
56. Lints TJ, Parsons LM, Hartley L et al. (1993). Nkx-2.5: A novel murine homeobox gene expressed in early heart progenitor cells and their myogenic descendants. Development 119, 419-431.
57. Lips DJ, van der Nagel T, Steendijk P et al. (2004). Left ventricular pressure-volume measurements in mice: Comparison of closed-chest versus open-chest approach. Basic Res Cardiol 99, 351-359.
58. Mangi AA, Noiseux N, Kong D et al. (2003). Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9, 1195-1201.
59. Mansour S, Van der Heyden M, De Bruyne B et al. (2006). Intracoronary delivery of hematopoietic bone marrow stem cells and luminal loss of the infarct-related artery in patients with recent myocardial infarction. J Am Coll Cardiol 47, 1727-1730.
60. Martin GR (1981). Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 78, 7634-7638.
61. Matsuura K, Nagai T, Nishigaki N et al. (2004). Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem 279, 11384-11391.
62. Menasche P (2004). Skeletal myoblast transplantation for cardiac repair. Expert Rev Cardiovasc Ther 2, 21-28.
63. Menasche P, Hagege AA, Vilquin JT et al. (2003). Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41, 1078-1083.
64. Messina E, De Angelis L, Frati G et al. (2004). Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 95, 911-921.
65. Meyer N, Jaconi M, Landopoulou A et al. (2000). A fluorescent reporter gene as a marker for ventricular specification in ES-derived cardiac cells. FEBS Lett 478, 151-158.
66. Meyer GP, Wollert KC, Lotz J et al. (2006). Intracoronary bone marrow cell transfer after myocardial infarction: Eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113, 1287-1294.
67. Min JY, Yang Y, Converso KL et al. (2002). Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J Appl Physiol 92, 288-296.
68. Muller M, Fleischmann BK, Selbert S et al. (2000). Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB J 14, 2540-2548.
69. Muller-Ehmsen J, Whittaker P, Kloner RA et al. (2002). Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol 34, 107-116.
70. Mummery C, Ward-van Oostwaard D, Doevendans P et al. (2003). Differentiation of human embryonic stem cells to cardiomyocytes: Role of coculture with visceral endoderm-like cells. Circulation 107, 2733-2740.
71. Murry CE, Soonpaa MH, Reinecke H et al. (2004). Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428, 664-668.
72. Naito H, Nishizaki K, Yoshikawa M et al. (2004). Xenogeneic embryonic stem cell-derived cardiomyocyte transplantation. Transplant Proc 36, 2507-2508.
73. Numaguchi Y, Sone T, Okumura K et al. (2006). The impact of the capability of circulating progenitor cell to differentiate on myocardial salvage in patients with primary acute myocardial infarction. Circulation 114, I114-I119.
74. Oh H, Bradfute SB, Gallardo TD et al. (2003). Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A 100, 12313-12318.
75. Orlic D, Kajstura J, Chimenti S et al. (2001). Bone marrow cells regenerate infarcted myocardium. Nature 410, 701-705.
76. Passier R, Denning C & Mummery C (2006). Cardiomyocytes from human embryonic stem cells. Handb Exp Pharmacol 174, 101-122.
77. Passier R & Mummery C (2003). Origin and use of embryonic and adult stem cells in differentiation and tissue repair. Cardiovasc Res 58, 324-335.
78. Passier R & Mummery C (2005). Cardiomyocyte differentiation from embryonic and adult stem cells. Curr Opin Biotechnol 16, 498-502.
79. Passier R, Oostwaard DW, Snapper J et al. (2005). Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures. Stem Cells 23, 772-780.
80. Piao H, Youn TJ, Kwon JS et al. (2005). Effects of bone marrow derived mesenchymal stem cells transplantation in acutely infarcting myocardium. Eur J Heart Fail 7, 730-738.
81. Rehman J, Li J, Orschell CM & March KL (2003). Peripheral blood 'endothelial progenitor cells' are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107, 1164-1169.
82. Reinecke H, Minami E, Poppa V et al. (2004). Evidence for fusion between cardiac and skeletal muscle cells. Circ Res 94, e56-e60.
83. Reinecke H, Poppa V & Murry CE (2002). Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol 34, 241-249.
84. Reubinoff BE, Pera MF, Fong CY et al. (2000). Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro. Nat Biotechnol 18, 399-404.
85. Ripa RS, Jorgensen E, Wang Y et al. (2006). Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Circulation 113, 1983-1992.
86. Schachinger V, Tonn T, Dimmeler S et al. (2006). Bone-marrow-derived progenitor cell therapy in need of proof of concept: Design of the REPAIR-AMI trial. Nat Clin Pract Cardiovasc Med 3 (Suppl. 1), S23-S28.
87. Singla DK, Hacker TA, Ma L et al. (2006). Transplantation of embryonic stem cells into the infarcted mouse heart: Formation of multiple cell types. J Mol Cell Cardiol 40, 195-200.
88. Smits AM, van Vliet P, Hassink RJ et al. (2005). The role of stem cells in cardiac regeneration. J Cell Mol Med 9, 25-36.
89. Swijnenburg RJ, Tanaka M, Vogel H et al. (2005). Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation 112, I166-I172.
90. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147.
91. Tian L, Catt JW, O'Neill C et al. (1997). Expression of immunoglobulin superfamily cell adhesion molecules on murine embryonic stem cells. Biol Reprod 57, 561-568.
92. Tomita S, Li RK, Weisel RD et al. (1999). Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100, II247-II256.
93. Watt AJ, Battle MA, Li J et al. (2004). GATA4 is essential for formation of the proepicardium and regulates cardiogenesis. Proc Natl Acad Sci U S A 101, 12573-12578.
94. Wollert KC, Meyer GP, Lotz J et al. (2004). Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 364, 141-148.
95. Xu C, Police S, Rao N et al. (2002). Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 91, 501-508.
96. Xue T, Cho HC, Akar FG et al. (2005). Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: Insights into the development of cell-based pacemakers. Circulation 111, 11-20.
97. Yang Y, Min JY, Rana JS et al. (2002). VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESC-differentiated cells. J Appl Physiol 93, 1140-1151.
98. Ziegelhoeffer T, Fernandez B, Kostin S et al. (2004). Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res 94, 230-238.
99. + cytolytic T cells. Nature 344, 742-746.
100. Zimmermann WH, Melnychenko I, Wasmeier G et al. (2006). Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 12, 452-458.